The landscape of dementia diagnosis has evolved considerably with the appearance of innovative biomarkers, which include amyloid PET scans, tau imaging, and blood-dependent checks which can detect Alzheimer's pathology years before symptoms arise. While these technological advances represent remarkable development in being familiar with neurodegenerative disorders, they have got not https://kedarj420lvf0.wikicorrespondence.com/user